Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
B-J Kullberg(Radboud University Nijmegen), JD Sobel(Wayne State University), Markus Ruhnke(Humboldt-Universität zu Berlin), PG Pappas(University of Alabama), Claudio Viscoli(Alleanza Contro il Cancro), John Rex(The University of Texas Health Science Center at Houston), JD Cleary(University of Mississippi), Eric Rubinstein(Tel Aviv University), LWP Church(Medical University of South Carolina), J. Martin Brown(University of the Witwatersrand), HT Schlamm(Pfizer (United States)), IT Oborska(Pfizer (United States)), Fiona Hilton(Pfizer (United States)), MR Hodges(Pfizer (United States))
Cited by 522
Abstract
Related Papers
No related papers found
Powered by citation graph analysis